Related Experiment Video
Updated: Aug 12, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Respiratory failure following talc pleurodesis
D H Rehse1, R W Aye, M G Florence
1Department of Surgery, Swedish Medical Center, Seattle, Washington, USA.
Talc pleurodesis, a common procedure, showed a high rate of serious complications, including adult respiratory distress syndrome, in a recent institutional review. These findings question the overall safety of talc pleurodesis.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Critical Care Medicine
Background:
- Sterile talc is the standard agent for pleurodesis.
- Talc pleurodesis is generally considered safe and effective.
- A recent case of severe pneumonitis prompted a safety review.
Purpose of the Study:
- To review the safety and complication rates of talc pleurodesis.
- To identify potential risk factors for adverse events.
Main Methods:
- Retrospective review of patients undergoing talc pleurodesis (December 1993 - December 1997).
- Documentation of respiratory and other complications.
- Statistical analysis using Student's t test and Pearson correlations.
Main Results:
- Eighty-nine procedures were performed on 78 patients.
- 33% of patients experienced respiratory complications or death.
- 9% developed adult respiratory distress syndrome (ARDS).
- No significant differences in outcomes based on patient groups, application methods, or talc dosages were found.
Conclusions:
- This study revealed a higher rate of serious complications than previously reported.
- The exact reasons for these adverse outcomes remain unclear.
- The safety of talc pleurodesis is called into question by these findings.
Related Concept Videos
Pleura of the Lungs
Acute Respiratory Failure-III
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pneumothorax II: Pathophysiology

